Search research articles
Contact Us
Filters
Showing results (271-280 of 305) with videos related to
Page
of 31
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
April 3, 2025
Quality of Life and Toxicity in Patients With Pancreatic Ductal Adenocarcinoma Treated With Online Adaptive Stereotactic Magnetic Resonance Guided Radiation Therapy
Jasmijn M Westerhoff, Jacobien C M Scheepens, Fernanne F van Wolffelaar, et al.
European Urology Oncology
|
April 3, 2023
Salvage Stereotactic Reirradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: A Retrospective Multicenter Study
Paul Archer, Giulia Marvaso, Beatrice Detti, et al.
World Journal of Urology
|
March 13, 2019
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study
Luca Triggiani, Rosario Mazzola, Stefano Maria Magrini, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
March 26, 2021
Sequencing Life-Prolonging Agents in Castration-Resistant Prostate Cancer Patients: Comparison of Sequences With and Without <sup>223</sup>Ra
Orazio Caffo, Viviana Frantellizzi, Fabio Monari, et al.
European Urology Oncology
|
February 7, 2025
Results of Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma in a Large Multicenter Series
Ludwige Abancourt, Muhammad Ali, Magali Quivrin, et al.
Clinical and Translational Radiation Oncology
|
January 26, 2024
Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy: Real-world data from the E<sup>2</sup>-RADIatE OligoCare cohort
Renée Bultijnck, Mieke Van Hemelrijck, Valérie Fonteyne, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 25, 2025
Analysis of patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy with or without RT dose intensification: A multicenter retrospective study - ATLANTIS part I
Luca Nicosia, Marco Lorenzo Bonù, Ilaria Angelicone, et al.
Oncology Research and Treatment
|
January 9, 2022
Next-Generation Sequencing of Circulating Tumor DNA Can Optimize Second-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer after Progression on anti-EGFR Therapy: Time to Rethink Our Approach
Davide Mauri, Konstantinos Kamposioras, Dimitrios Matthaios, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 2, 2024
Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E<sup>2</sup>-RADIatE OligoCare cohort
Filippo Alongi, Luca Nicosia, Umberto Ricardi, et al.
Critical Reviews in Oncology/Hematology
|
January 20, 2019
Combination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy
Stefano Arcangeli, Barbara Alicia Jereczek-Fossa, Filippo Alongi, et al.
Page
of 31
Search research articles
Search
Showing results (271-280 of 305) with videos related to
Sort By:
Page
of 31
International Journal of Radiation Oncology, Biology, Physics
|
April 3, 2025
Quality of Life and Toxicity in Patients With Pancreatic Ductal Adenocarcinoma Treated With Online Adaptive Stereotactic Magnetic Resonance Guided Radiation Therapy
Jasmijn M Westerhoff, Jacobien C M Scheepens, Fernanne F van Wolffelaar, et al.
European Urology Oncology
|
April 3, 2023
Salvage Stereotactic Reirradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: A Retrospective Multicenter Study
Paul Archer, Giulia Marvaso, Beatrice Detti, et al.
World Journal of Urology
|
March 13, 2019
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study
Luca Triggiani, Rosario Mazzola, Stefano Maria Magrini, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
March 26, 2021
Sequencing Life-Prolonging Agents in Castration-Resistant Prostate Cancer Patients: Comparison of Sequences With and Without <sup>223</sup>Ra
Orazio Caffo, Viviana Frantellizzi, Fabio Monari, et al.
European Urology Oncology
|
February 7, 2025
Results of Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma in a Large Multicenter Series
Ludwige Abancourt, Muhammad Ali, Magali Quivrin, et al.
Clinical and Translational Radiation Oncology
|
January 26, 2024
Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy: Real-world data from the E<sup>2</sup>-RADIatE OligoCare cohort
Renée Bultijnck, Mieke Van Hemelrijck, Valérie Fonteyne, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 25, 2025
Analysis of patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy with or without RT dose intensification: A multicenter retrospective study - ATLANTIS part I
Luca Nicosia, Marco Lorenzo Bonù, Ilaria Angelicone, et al.
Oncology Research and Treatment
|
January 9, 2022
Next-Generation Sequencing of Circulating Tumor DNA Can Optimize Second-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer after Progression on anti-EGFR Therapy: Time to Rethink Our Approach
Davide Mauri, Konstantinos Kamposioras, Dimitrios Matthaios, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 2, 2024
Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E<sup>2</sup>-RADIatE OligoCare cohort
Filippo Alongi, Luca Nicosia, Umberto Ricardi, et al.
Critical Reviews in Oncology/Hematology
|
January 20, 2019
Combination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy
Stefano Arcangeli, Barbara Alicia Jereczek-Fossa, Filippo Alongi, et al.
Page
of 31